Comparison of Serum Vitamin D Levels in Relation to Bowel and Bladder Symptoms in Women with Vulvar Diseases
Abstract
Abstract.Objectives: We sought to investigate associations between vitamin D levels and bowel and bladder disorders in women with vulvar diseases.
Methods: This is a planned sub-analysis of a cross-sectional study comparing the prevalence of bowel and bladder symptoms in women with biopsy-proven vulvar lichen sclerosus (LS) to a control group of women with non-lichenoid vulvar diseases. All subjects were recruited from a tertiary referral vulvar care clinic in a university-based practice. Serum vitamin D levels were measured and subjects self-completed questionnaires during study recruitment. Pelvic floor disorders were determined from the following questionnaires: Rome III Functional Bowel Disorders Questionnaire, the Bristol stool scale, the Medical, Social and Epidemiologic Aspects of Aging Questionnaire, and the Overactive Bladder-8 Question Version.
Results: 181 women with vulvar diseases were included: 88 with LS and 93 with non-LS vulvar diseases. The mean age was 52.5 ± 15.3 years, and 94.5% were Caucasian. Vitamin D levels (26.8 ± 13.1 vs 29.5 ± 19.0 ng/mL), prevalence of low vitamin D levels (51.1% vs 45.2%), and vitamin D supplementation (42.0% vs 47.8%) were similar in women with and without LS (p ≥ 0.27). These factors did not differ between women with and without overactive bladder (OAB) (vitamin D levels 30.1 ± 17.8 vs 26.3 ± 14.8 ng/mL), urinary incontinence (27.9 ± 15.2 vs 26.4 ± 11.0 ng/mL), constipation (26.7 ± 14.8 vs 28.5 ± 16.8 ng/mL), or irritable bowel syndrome (IBS) (30.8 ± 22.1 vs 27.6 ± 13.4 ng/mL).
Conclusions: In this cohort of women with vulvar diseases, vitamin D levels and supplementation were not significantly different amongst women with vulvar lichen sclerosus or other non-lichenoid vulvar diseases. Furthermore, vitamin D levels are not serum biomarkers for OAB, urinary incontinence, constipation, or IBS.
References
1 Acog practice bulletin no. 93: Diagnosis and management of vulvar skin disorders. (2008) Obstet Gynecol. 111, 1243–1253.
2 (2008) Prevalence of symptomatic pelvic floor disorders in us women. JAMA. 300, 1311–1316.
3 (2007) Bladder and bowel symptoms among women with vulvar disease: Are they universal? J Reprod Med. 52, 1073–1078.
4 (2012) Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus. J Low Genit Tract Dis. 16, 285–289.
5 (2009) Global vitamin D status and determinants of hypovitaminosis d. Osteoporos Int. 20, 1807–1820.
6 (2015) Vitamin D deficiency in postmenopausal women with pelvic floor disorders. J Midlife Health. 6, 66–69.
7 (2000) Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr. 31, 1–4.
8 (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol.. 4, 404–412.
9 (2003) Oral calcitriol: A new therapeutic agent in cutaneous lichen sclerosis. J Drugs Dermatol. 2, 23–28.
10 (2005) Treatment of genital lichen sclerosus with topical calcipotriol. Int J STD AIDS. 16, 772–774.
11 (2014) Vitamin D deficiency is associated with increased fecal incontinence symptoms. Int Urogynecol J. 25, 1483–1489.
12 (2012) Phase iib, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine effects of elocalcitol in women with overactive bladder and idiopathic detrusor overactivity. Urology. 80, 48–54.
13 (2015) Lower urinary tract and functional bowel symptoms in women with vulvar diseases and controls. Female Pelvic Med Reconstr Surg. 21, 211–214.
14 (2006) Functional bowel disorders. Gastroenterology. 130, 1480–1491.
15 (1990) Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ. 300, 439–440.
16 (1990) Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults. J Gerontol. 45, M67–74.
17 (2005) Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther. 22, 381–394.
18 (2016) Vitamin D and incident urinary incontinence in older adults. Eur J Clin Nutr. 70, 987–989.
19 (2016) Hypovitaminosis D is an independent associated factor of overactive bladder in older adults. Arch Gerontol Geriatr. 65, 128–132.
20 (2010) Vitamin D and pelvic floor disorders in women: Results from the national health and nutrition examination survey. Obstet Gynecol. 115, 795–803.
21 (2017) Role of vitamin D in urogenital health of geriatric participants. J Midlife Health. 8, 28–35.
22 (2017) Vitamin D and urinary incontinence among korean women: A propensity score-matched analysis from the 2008–2009 korean national health and nutrition examination survey. J Korean Med Sci. 32, 661–665.
23 (2015) The effect of vitamin D on vaginal atrophy in postmenopausal women. Iran J Nurs Midwifery Res. 20, 211–215.
24 (2016) Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab. 101, 394–415.